1. ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers. (September 2016) Authors: Bisgaier, Charles L.; Ackermann, Rose; Rea, Thomas; Rodrigueza, Wendi V.; Hartman, Daniel Journal: Pharmacological research Issue: Volume 111(2016:Sep.) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers. (September 2016) Authors: Bisgaier, Charles L.; Ackermann, Rose; Rea, Thomas; Rodrigueza, Wendi V.; Hartman, Daniel Journal: Pharmacological research Issue: Volume 111(2016:Sep.) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of a fipronil bait in reducing the number of fleas (Oropsylla spp.) infesting wild black‐tailed prairie dogs. Issue 1 (June 2017) Authors: Poché, David M.; Hartman, Daniel; Polyakova, Larisa; Poché, Richard M. Journal: Journal of vector ecology Issue: Volume 42:Issue 1(2017:Jun.) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of a topical formulation of eprinomectin against Anopheles arabiensis when administered to Zebu cattle (Bos indicus) under field conditions. (December 2016) Authors: Lozano-Fuentes, Saul; Kading, Rebekah; Hartman, Daniel; Okoth, Edward; Githaka, Naftaly; Nene, Vishvanath; Poché, Richard Journal: Malaria journal Issue: Volume 15:Number 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. From Molecule to Patient: A Biotech Perspective. Issue 1 (20th November 2019) Authors: Langer, Robert; Jaklenec, Ana; Traverso, Giovanni; Hartman, Daniel Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 1(2020) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension. Issue 3 (14th December 2012) Authors: Karns, Adam D.; Bral, Jacqueline M.; Hartman, Daniel; Peppard, Thomas; Schumacher, Christoph Journal: Journal of clinical hypertension Issue: Volume 15:Issue 3(2013:Mar.) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The World Health Organization Prequalification Program and Clinical Pharmacology in 2030. Issue 1 (26th November 2019) Authors: Blaschke, Terrence F.; Lumpkin, Murray; Hartman, Daniel Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 1(2020) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World. Issue 1 (31st October 2021) Authors: McNair, Douglas; Lumpkin, Murray; Kern, Steven; Hartman, Daniel Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 1(2022) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. What's at Stake: Evaluating a Run-Hide-Fight® Intervention Video through the Lens of Vested Interest Theory. Issue 12 (1st December 2020) Authors: Skurka, Chris; Reynolds-Tylus, Tobias; Quick, Brian; Hartman, Daniel Journal: Journal of health communication Issue: Volume 25:Issue 12(2020) Page Start: 982 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗